# NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment

> **NCT06537154** · PHASE2,PHASE3 · RECRUITING · sponsor: **Peter Black** · enrollment: 688 (estimated)

## Conditions studied

- Muscle-Invasive Bladder Carcinoma

## Interventions

- **PROCEDURE:** Active Surveillance
- **PROCEDURE:** Control arm - Definitive bladder treatment

## Key facts

- **NCT ID:** NCT06537154
- **Lead sponsor:** Peter Black
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-28
- **Primary completion:** 2028-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 688 (ESTIMATED)
- **Last updated:** 2025-07-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06537154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06537154, "NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06537154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*